1. Home
  2. VNDA vs TSAT Comparison

VNDA vs TSAT Comparison

Compare VNDA & TSAT Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

  • Machine Learning Prediction
  • ML Decision
  • VNDA
  • TSAT
  • Stock Information
  • Founded
  • VNDA 2002
  • TSAT 1969
  • Country
  • VNDA United States
  • TSAT Canada
  • Employees
  • VNDA N/A
  • TSAT N/A
  • Industry
  • VNDA Biotechnology: Pharmaceutical Preparations
  • TSAT Metal Fabrications
  • Sector
  • VNDA Health Care
  • TSAT Industrials
  • Exchange
  • VNDA Nasdaq
  • TSAT Nasdaq
  • Market Cap
  • VNDA 288.2M
  • TSAT 233.1M
  • IPO Year
  • VNDA 2006
  • TSAT 1996
  • Fundamental
  • Price
  • VNDA $4.78
  • TSAT $23.41
  • Analyst Decision
  • VNDA Strong Buy
  • TSAT
  • Analyst Count
  • VNDA 3
  • TSAT 0
  • Target Price
  • VNDA $15.33
  • TSAT N/A
  • AVG Volume (30 Days)
  • VNDA 421.0K
  • TSAT 170.5K
  • Earning Date
  • VNDA 07-30-2025
  • TSAT 08-13-2025
  • Dividend Yield
  • VNDA N/A
  • TSAT N/A
  • EPS Growth
  • VNDA N/A
  • TSAT N/A
  • EPS
  • VNDA N/A
  • TSAT N/A
  • Revenue
  • VNDA $201,351,000.00
  • TSAT $372,642,710.00
  • Revenue This Year
  • VNDA $16.86
  • TSAT N/A
  • Revenue Next Year
  • VNDA $39.78
  • TSAT N/A
  • P/E Ratio
  • VNDA N/A
  • TSAT N/A
  • Revenue Growth
  • VNDA 13.37
  • TSAT N/A
  • 52 Week Low
  • VNDA $3.81
  • TSAT $7.21
  • 52 Week High
  • VNDA $6.37
  • TSAT $27.45
  • Technical
  • Relative Strength Index (RSI)
  • VNDA 53.88
  • TSAT 65.95
  • Support Level
  • VNDA $4.85
  • TSAT $25.26
  • Resistance Level
  • VNDA $5.12
  • TSAT $27.45
  • Average True Range (ATR)
  • VNDA 0.18
  • TSAT 1.70
  • MACD
  • VNDA 0.01
  • TSAT 0.01
  • Stochastic Oscillator
  • VNDA 54.05
  • TSAT 66.48

About VNDA Vanda Pharmaceuticals Inc.

Vanda Pharmaceuticals Inc is a biopharmaceutical company engaged in the development and commercialization of therapies to address high unmet medical needs and improve the lives of patients. Its commercial portfolio comprises three products; HETLIOZ for the treatment of Non-24-Hour Sleep-Wake Disorder (Non-24) & nighttime sleep disturbances in Smith-Magenis Syndrome (SMS); Fanapt for the treatment of schizophrenia; and PONVORY. Its other products include VHX-896, ASO Molecules, VQW-765, Tradipitant, VTR-297 and VHX-896. The majority of revenue is derived from the Fanapt product sales. Geographically, the company sells its product predominantly in the United States, and also in Israel, Europe, and Canada.

About TSAT Telesat Corporation and Class B Variable Voting Shares

Telesat Corp is a satellite operator, that provides its customers with mission-critical communications services. It operates in a single operating segment, in which it provides satellite-based services to its broadcast, enterprise, and consulting customers around the world. Geographically, it derives a majority of its revenue from Canada. It derives revenue from Broadcast, Enterprise, Consulting, and others.

Share on Social Networks: